SCHEMBL4391759

SCHEMBL4391759

COC(=O)C(C(C)=O)c1cc(O)cc(O)c1-c1cccc(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
ACLY P53396 1/20 0.41
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
ADORA3 P0DMS8 2/20 0.38
ADORA2B P29275 2/20 0.38
ADORA1 P30542 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ADORA2A P29274 1/20 0.38
AKR1C3 P42330 2/20 0.38
AKR1C2 P52895 2/20 0.38
AKR1C4 P17516 1/20 0.38
AKR1C1 Q04828 1/20 0.38
HSD17B2 P37059 1/20 0.38
ERN1 O75460 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394066 0.86 PDE4B (0.40) HSP90AA1ALDH1A1MAPT
SCHEMBL4380721 0.82 AKR1C3 (0.44) HDAC4HDAC8ACLYKDM4EAKR1C3
SCHEMBL4392467 0.78 HSP90AA1 (0.40) HSP90AA1HSP90AB1ADORA3ADORA2BADORA1
SCHEMBL4380826 0.76 CAPN1 (0.38) HSP90AA1HSP90AB1SMN1; SMN2ALDH1A1NPC1
SCHEMBL6312058 0.72 MTNR1A (0.51) ALDH1A1NPC1RAB9A
SCHEMBL4382035 0.72 HDAC4 (0.46) HDAC4HDAC8ACLYHSP90AB1KDM4E
SCHEMBL4387624 0.69 PDE4B (0.41) HSP90AA1MAPT
SCHEMBL4379804 0.69 PDE4B (0.41) HSP90AA1MAPT
SCHEMBL16344805 0.68 CYP3A4 (0.46) KDM4EALDH1A1HPGDNPC1HTT
SCHEMBL27613029 0.68 HDAC4 (0.66) HDAC4HDAC8ACLYERN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P HDAC4 985/4885HDAC8 94/4885ACLY 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.